Research graph
References from A review of policy actions implemented during a toxic drug public health emergency in British Columbia, Canada (2016–2024). Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2026 · External reference
Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada
10.1016/j.drugpo.2021.103237 · 2021 · External reference
Unresolved reference
2026 · External reference
Unresolved reference
2026 · External reference
Implementing Foundry: A cohort study describing the regional and virtual expansion of a youth integrated service in British Columbia, Canada
10.1111/eip.13538 · 2024 · External reference
Unresolved reference
2025 · External reference
Unresolved reference
2025 · External reference
Unresolved reference
2025 · External reference
Unresolved reference
External reference
Unresolved reference
2026 · External reference
Unresolved reference
2018 · External reference
Unresolved reference
2026 · External reference
Unresolved reference
2026 · External reference
Evaluating complex transformation: British Columbia’s provincial response to the overdose public health emergency
10.1108/jhom-05-2019-0139 · 2019 · External reference
Responding to changes in the unregulated drug supply: The need for a dynamic approach to drug checking technologies
10.1080/00952990.2023.2226312 · 2023 · External reference
Understanding risk and protective factors associated with opioid misuse among at-risk adolescents and young adults in the emergency department
10.1016/j.drugalcdep.2025.112814 · 2025 · External reference
Unresolved reference
2026 · External reference
The origins of Canadian narcotics legislation: The process of criminalization in historical context
1984 · External reference
Lessons from INSITE, Vancouver's supervised injection facility: 2003–2012
2013 · External reference
The harms of drug prohibition: Ongoing resistance in Vancouver’s downtown eastside
2019 · External reference
Unresolved reference
2009 · External reference
Unresolved reference
2026 · External reference
Unresolved reference
2026 · External reference
Unresolved reference
2026 · External reference
Unresolved reference
2026 · External reference
Unresolved reference
2024 · External reference
Unresolved reference
2026 · External reference
Unresolved reference
External reference
Unresolved reference
2026 · External reference
Addressing racial and ethnic inequities in opioid overdose mortality: Strategies for equitable interventions and structural change
10.1007/s11920-024-01556-7 · 2024 · External reference
Unresolved reference
2026 · External reference
Unresolved reference
2024 · External reference
Unresolved reference
2008 · External reference
Unresolved reference
2026 · External reference
Unresolved reference
2026 · External reference
"It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances
10.1186/s12889-023-15474-5 · 2023 · External reference
Unresolved reference
2020 · External reference
Unresolved reference
2026 · External reference
Unresolved reference
2026 · External reference
Unresolved reference
2026 · External reference
Impact of opioid overdoses on US life expectancy and years of life lost, by demographic group and stimulant co-involvement: A mortality data analysis from 2019 to 2022
2024 · External reference
Unresolved reference
External reference
'I'm on the coast and I'm on methadone': A qualitative study examining access to opioid agonist treatment in rural and coastal British Columbia
10.4103/cjrm.cjrm_56_23 · 2024 · External reference
The short-term impacts of decriminalisation of personal possession of select illegal drugs on drug poisonings in British Columbia, Canada (2015–2023)
10.1111/dar.70036 · 2025 · External reference
The impact of the novel coronavirus disease (COVID-19) pandemic on drug overdose-related deaths in the United States and Canada: A systematic review of observational studies and analysis of public health surveillance data
10.1186/s13011-021-00423-5 · 2021 · External reference
Public support of and attitudes toward decriminalization of possession of illegal drugs among the general population in British Columbia
10.1186/s13011-025-00680-8 · 2025 · External reference
A systematic review of stakeholder perceptions of supervised injection facilities
10.1016/j.drugalcdep.2019.02.006 · 2019 · External reference
“Its baneful influences are too well known”: Debates over drug use in Canada, 1867–1908
1997 · External reference
Unresolved reference
2026 · External reference
Public support for safer supply programs: Analysis of a cross-sectional survey of Canadians in two provinces
10.17269/s41997-022-00736-3 · 2023 · External reference
Applying the lessons of COVID-19 response to Canada's worsening opioid epidemic
2020 · External reference
Bed-based care as a response to the overdose crisis: An approach to informing and evaluating proposed expansion
10.1503/cmaj.240955 · 2025 · External reference
Rehabilitation and the narcotic addict: Results of a comparative methadone withdrawal program
1967 · External reference
Implementation of pharmaceutical alternatives to a toxic drug supply in British Columbia: A mixed methods study
10.1016/j.josat.2024.209341 · 2024 · External reference
Unresolved reference
External reference
Population perinatal substance use and an environmental scan of health services in British Columbia, Canada
10.1016/j.drugalcdep.2024.112457 · 2024 · External reference
Unresolved reference
2026 · External reference
Unresolved reference
2026 · External reference
Unresolved reference
2026 · External reference
Chapter 13 strengthening health systems to provide emergency care
2017 · External reference
The increase in benzodiazepine-laced drugs and related risks in Canada: The urgent need for effective and sustainable solutions
10.1016/j.drugpo.2022.103933 · 2023 · External reference
How should harm reduction be included in care continua for patients with opioid use disorder?
10.1001/amajethics.2024.562 · 2024 · External reference
"Everything is not right anymore": Buprenorphine experiences in an era of illicit fentanyl
10.1016/j.drugpo.2019.09.003 · 2019 · External reference
Trajectories of retention in opioid agonist therapy in a Canadian setting
10.1016/j.drugpo.2020.102696 · 2020 · External reference
Unresolved reference
2026 · External reference
Unresolved reference
2026 · External reference
Unresolved reference
2026 · External reference
Unresolved reference
2026 · External reference
A qualitative study exploring how young people perceive and experience substance use services in British Columbia, Canada
10.1186/s13011-022-00456-4 · 2022 · External reference
Unresolved reference
2023 · External reference
Access and barriers to safer supply prescribing during a toxic drug emergency: A mixed methods study of implementation in British Columbia, Canada
10.1186/s13011-024-00625-7 · 2024 · External reference
Public support for harm reduction: A population survey of Canadian adults
10.1371/journal.pone.0251860 · 2021 · External reference
Unresolved reference
External reference
Opioid agonist therapy discontinuation in British Columbia: A cross-sectional study of people who access harm reduction services
10.1136/bmjopen-2024-090704 · 2025 · External reference
How should harm reduction be included in care continua for patients with opioid use disorder?
10.1001/amajethics.2024.562 · ExternalCitation · doi-reference
Addressing racial and ethnic inequities in opioid overdose mortality: Strategies for equitable interventions and structural change
10.1007/s11920-024-01556-7 · ExternalCitation · doi-reference
A systematic review of stakeholder perceptions of supervised injection facilities
10.1016/j.drugalcdep.2019.02.006 · ExternalCitation · doi-reference
Population perinatal substance use and an environmental scan of health services in British Columbia, Canada
10.1016/j.drugalcdep.2024.112457 · ExternalCitation · doi-reference
Understanding risk and protective factors associated with opioid misuse among at-risk adolescents and young adults in the emergency department
10.1016/j.drugalcdep.2025.112814 · ExternalCitation · doi-reference
"Everything is not right anymore": Buprenorphine experiences in an era of illicit fentanyl
10.1016/j.drugpo.2019.09.003 · ExternalCitation · doi-reference
Trajectories of retention in opioid agonist therapy in a Canadian setting
10.1016/j.drugpo.2020.102696 · ExternalCitation · doi-reference
Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada
10.1016/j.drugpo.2021.103237 · ExternalCitation · doi-reference
The increase in benzodiazepine-laced drugs and related risks in Canada: The urgent need for effective and sustainable solutions
10.1016/j.drugpo.2022.103933 · ExternalCitation · doi-reference
Implementation of pharmaceutical alternatives to a toxic drug supply in British Columbia: A mixed methods study
10.1016/j.josat.2024.209341 · ExternalCitation · doi-reference
Responding to changes in the unregulated drug supply: The need for a dynamic approach to drug checking technologies
10.1080/00952990.2023.2226312 · ExternalCitation · doi-reference
Evaluating complex transformation: British Columbia’s provincial response to the overdose public health emergency
10.1108/jhom-05-2019-0139 · ExternalCitation · doi-reference
The short-term impacts of decriminalisation of personal possession of select illegal drugs on drug poisonings in British Columbia, Canada (2015–2023)
10.1111/dar.70036 · ExternalCitation · doi-reference
Implementing Foundry: A cohort study describing the regional and virtual expansion of a youth integrated service in British Columbia, Canada
10.1111/eip.13538 · ExternalCitation · doi-reference
Opioid agonist therapy discontinuation in British Columbia: A cross-sectional study of people who access harm reduction services
10.1136/bmjopen-2024-090704 · ExternalCitation · doi-reference
"It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances
10.1186/s12889-023-15474-5 · ExternalCitation · doi-reference
The impact of the novel coronavirus disease (COVID-19) pandemic on drug overdose-related deaths in the United States and Canada: A systematic review of observational studies and analysis of public health surveillance data
10.1186/s13011-021-00423-5 · ExternalCitation · doi-reference
A qualitative study exploring how young people perceive and experience substance use services in British Columbia, Canada
10.1186/s13011-022-00456-4 · ExternalCitation · doi-reference
Access and barriers to safer supply prescribing during a toxic drug emergency: A mixed methods study of implementation in British Columbia, Canada
10.1186/s13011-024-00625-7 · ExternalCitation · doi-reference
Public support of and attitudes toward decriminalization of possession of illegal drugs among the general population in British Columbia
10.1186/s13011-025-00680-8 · ExternalCitation · doi-reference
Public support for harm reduction: A population survey of Canadian adults
10.1371/journal.pone.0251860 · ExternalCitation · doi-reference
Bed-based care as a response to the overdose crisis: An approach to informing and evaluating proposed expansion
10.1503/cmaj.240955 · ExternalCitation · doi-reference
Public support for safer supply programs: Analysis of a cross-sectional survey of Canadians in two provinces
10.17269/s41997-022-00736-3 · ExternalCitation · doi-reference
'I'm on the coast and I'm on methadone': A qualitative study examining access to opioid agonist treatment in rural and coastal British Columbia
10.4103/cjrm.cjrm_56_23 · ExternalCitation · doi-reference
